In primary open angle glaucoma, elevated BMP antagonist expressed by TM cells inhibits BMP-4 antagonism of TGF-β2 and this inhibition leads to increased ECM deposition and elevated IOP [13]. The gene discussed is BMP4; the disease is open-angle glaucoma.